Events calendar: page 3

The programme will include topics on transcription, RNA processing and modification, mRNA export and localisation, mRNA surveillance and decay, translation, the activity of non-coding RNAs, the control of mRNA expression, and coupling among these processes.

Session topics
Co-transcriptional RNA biology
RNA processing and modification
RNP on the move
Co-translational RNA biology
RNA structure and regulation
RNA pathogens and therapeutics

Organizers: Elena Conti MAX PLANCK INSTITUTE OF BIOCHEMISTRY, GERMANY Olivier Duss EMBL HEIDELBERG, GERMANY Torben Heick Jensen AARHUS UNIVERSITY, DENMARK Karla Neugebauer YALE SCHOOL OF MEDICINE, USA

Conference Chairs: Prof. Dr. Uwe Völker
Interfaculty Institute of Genetics and Functional Genomics
Felix-Hausdorff-Straße 8
17475 Greifswald, Germany

Prof. Dr. Ruth Huttenhain
Department of Molecular & Cellular Physiology
Stanford University of Medicine, USA

Prof. Dr. Bernd Wollscheid
Head of Institute of Translational Medicine
Department of Health Sciences and Technology
ETH Zürich, Switzerland

Conference Language: The official conference language will be English.
Area of expertise: Cell biology, proteomics, genetics

Organizers: Conventus Congressmanagement & Marketing GmbH

This is the 12th Annual Meeting of the International Cytokine & Interferon Society (ICIS), jointly held with the Korean Association of Immunologists (KAI) International Meeting 2024.

The scientific program includes 2 Keynote Lectures and 19 symposium Sessions as well as several social events. Dr. Drew Weissman, the winner of 2023 Nobel Prize in Medicine or Physiology, is one of the Keynote Lecturers, and more than 50 world-renowned scientists working in the field of cytokine biology will participate in the event as invited speakers. There will also be a large number of abstracts selected for oral presentation and plenty of time for poster presentations, to help young and upcoming scientists share their research, and network with other attendees.

Organizers: International Cytokine & Interferon Society, Korean Association of Immunologists

There has been tremendous progress in the past few years regarding our understanding of DNA replication in eukaryotes, both yeast and mammals. Many important questions in the field are poised to be answered within the next decade. These include understanding DNA replication at the biochemical and three-dimensional protein structure levels. In addition, studies using high throughput technologies at the cellular and organismal levels are poised to answer how accurate replication of the genome is ensured by controlling origin firing in space and time.

Organizers: Anja Groth UNIVERSITY OF COPENHAGEN, DENMARK Thanos Halazonetis UNIVERSITÉ DE GENÈVE, SWITZERLAND Helle Ulrich INSTITUTE OF MOLECULAR BIOLOGY GGMBH, GERMANY

The EMBL Conference ‘The next generation in infection biology’ is a platform for late-stage postdoctoral scientists in the field of infection biology to present their work and connect with the leading European institutions in infection biology. The speakers will be chosen for their track record of research accomplishments and their high-reaching future plans. The audience will have the unique opportunity to experience cutting-edge science presented by the rising leaders in this field. The institutional partners will provide discussion and networking opportunities to connect and shape the future league of infection biologists in Europe.

Organizers: Maria Bernabeu EMBL BARCELONA, SPAIN Jan Kosinski EMBL HAMBURG, GERMANY Eva Kowalinski EMBL GRENOBLE, FRANCE John Lees EMBL-EBI, UK Lizette de Paula EMBL HEIDELBERG, GERMANY Nassos Typas EMBL HEIDELBERG, GERMANY

Join us at the ProCan-hosted International Conference, ‘Advancing Multi-Omics into the Clinic’, Sydney – Australia, 18th-19th November 2024. Through this two-day meeting, internationally renowned experts in proteomics, genomics, cancer management, biomarker and drug discovery will share their progress towards addressing the challenges and opportunities of multi-omic data integration in cancer management, with a special focus on the role of proteomics in advancing biomarker development and drug discovery.

Speakers include:
Prof Ruedi Aebersold | ETH, Zurich | Switzerland
Prof Bernhard Kuster | TUM, Munich | Germany
Prof Jennifer Van Eyk | Cedars-Sinai, Los Angeles | USA
Prof David Thomas | University of New South Wales | Australia
Dr Christopher Whelan | UKB – PPP | USA
Prof Bing Zhang | BCM, Houston| USA

Contact
[email protected]

Organizers: Children Medical Research Institute, ProCan